By GINA KOLATA from NYT Health
https://ift.tt/2DOZiTD
Powerful PCSK9 inhibitors were supposed to revolutionize care for cardiac patients. But insurers and other payers balked at sky-high prices.
These Cholesterol-Reducers May Save Lives. So Why Aren’t Heart Patients Getting Them?
By GINA KOLATA from NYT Health
https://ift.tt/2DOZiTD
Powerful PCSK9 inhibitors were supposed to revolutionize care for cardiac patients. But insurers and other payers balked at sky-high prices.
No comments:
Post a Comment